The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna

[1] Guthrie JR(1996)Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women Obstet Gynecol 88 437-442

[2] Dennerstein L(2001)Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review Climacteric 4 58-74

[3] Hopper JL(1999)Effect of age on reasons for initiation and discontinuation of hormone replacement therapy Menopause 6 282-289

[4] Burger HG(2001)Why do older women discontinue hormone replacement therapy? J Womens Health Gend Based Med 10 343-350

[5] MacLennan A(2003)Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419-427

[6] Lester S(2002)Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II) JAMA 288 58-66

[7] Moore V(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321-333

[8] Ettinger B(2003)Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy Obstet Gynecol 102 1225-1232

[9] Pressman A(2002)Use of alternative therapies for menopause symptoms: results of a population-based study Obstet Gynecol 100 18-25

[10] Silver P(1997)Alternative drug use for the climacteric in Finland Maturitas 27 5-11

[1] Guthrie JR(1996)Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women Obstet Gynecol 88 437-442

[2] Dennerstein L(2001)Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review Climacteric 4 58-74

[3] Hopper JL(1999)Effect of age on reasons for initiation and discontinuation of hormone replacement therapy Menopause 6 282-289

[4] Burger HG(2001)Why do older women discontinue hormone replacement therapy? J Womens Health Gend Based Med 10 343-350

[5] MacLennan A(2003)Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419-427

[6] Lester S(2002)Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II) JAMA 288 58-66

[7] Moore V(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321-333

[8] Ettinger B(2003)Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy Obstet Gynecol 102 1225-1232

[9] Pressman A(2002)Use of alternative therapies for menopause symptoms: results of a population-based study Obstet Gynecol 100 18-25

[10] Silver P(1997)Alternative drug use for the climacteric in Finland Maturitas 27 5-11